| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc6b874671d5e23de3c12f1ef48466c7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 |
| filingDate |
2022-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_121a8cd1e673625a9ab657d426cf124e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2060145a30fdbc8cbd9ae2910cdd77c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd9df0910bb54893efa55dbdd44507c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c97ab17bba6c9b81dd40aaa1925ba289
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02ef04fd13f79659a969867543dbbab1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b282d0f389168107e6efeddb5fd9a6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c76758f2a8ea6013ef318dca902d03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb3fc561825dc5b0e18f3d2eaaa19cdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e65bd1cf96d1cb6da777525c32ee8ef |
| publicationDate |
2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-102022002332-A2 |
| titleOfInvention |
METHOD FOR THE TREATMENT OF COVID-19 INFECTIONS WITH PALMITOYLETHHANOLAMIDE |
| abstract |
METHOD FOR THE TREATMENT OF COVID-19 INFECTIONS WITH PALMITOYLETHHANOLAMIDE. The present invention relates to a method of treating a COVID-19 infection by administering an effective amount of an endogenous compound devoid of significant toxicity. In particular, the present invention relates to a method of treating a patient affected by COVID-19 infection, comprising administering an effective amount of a mixture of ultramicronized palmitoylethanolamide and micronized palmitoylethanolamide to said patient. |
| priorityDate |
2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |